| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916088 | Nuclear Medicine and Biology | 2012 | 11 Pages |
Abstract
Based on microPET imaging experiments that show high-quality, high-contrast images with virtually no residual gastrointestinal radioactivity, this new heterodimeric RGD-BBN conjugate can be considered as a promising PET tracer candidate for the diagnosis of GRPr-positive tumors in human patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrew B. Jackson, Prasant K. Nanda, Tammy L. Rold, Gary L. Sieckman, Ashley F. Szczodroski, Timothy J. Hoffman, Xiaoyuan Chen, Charles J. Smith,